Nature news story on publication of trial data

The story relates to an announcement on June 10 by the International Federation of Pharmaceutical Manufacturers and Associations.  An exerpt from the IFPMA press release states:

"Through the Position, the above associations and their member companies and associations commit, as a minimum, to submit for publication as a manuscript in a peer-reviewed journal, the results of all their industry-sponsored phase III clinical trials, as well as the results of other trials of significant medical importance. The new Joint Position requires submission for publication of the results of all trials within its scope, regardless of whether the outcome was positive or negative."

The full statement is here: Joint Position on the Publication of Clinical Trial Results in the Scientific Literature